Skip to main content

Advertisement

SpringerLink
Log in

Qishen Yiqi Dripping Pills for Cardiovascular Diseases: Effects and Mechanisms

  • Review
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Qishen Yiqi Dripping Pills (QSYQ) is a compound of Chinese medicine, which has been used to treat coronary heart disease and cardiac dysfunction. Its natural components include astragaloside IV, flavonoids, danshensu, protocatechualdehyde, salvianolic acid B, salvianolic acid A, ginsenosides Rg1, ginsenosides Rb1, and essential oils, etc. It exerts effects of nourishing qi and promoting blood circulation to relieve pain. In this review, the bioactive components of QSYQ and its effects for treating cardiovascular diseases and possible mechanism were summarized, providing references for further study and clinical application of QSYQ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shen XZ, He XJ. Study on effects of Qishen Yiqi Dropping Pills and double antiplatelets on cardiac function and BNP in patients with unstable angina pectoris of coronary heart disease. Liaoning J Tradit Chin Med (Chin) 2020;47:102–105.

    CAS  Google Scholar 

  2. Liu LW, Zhou L, Sun Z, et al. Main chemical constituents research of Qishen Yiqi Dropping Pills based on UHPLC-Q-Orbitrap HRMS. Chin Tradit Herb Drugs (Chin) 2018;49:5761–5771.

    Google Scholar 

  3. Ma L, Liu ZC, Gao SW, et al. Qishen Yiqi Dripping Pills regulate mitochondrial fusion through Sirt1/Mfn1 pathway and play a protective role in cardiac function after myocardial infarction. J Emerg Tradit Chin Med (Chin) 2022;31:568–572.

    Google Scholar 

  4. Anwaier G, Xie TT, Pan CS, et al. QiShenYiQi Pill ameliorates cardiac fibrosis after pressure overload-induced cardiac hypertrophy by regulating FHL2 and the macrophage RP S19/TGF-β1 signaling pathway. Front Pharmacol 2022;13:918335.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Chen YY, Li Q, Pan CS, et al. Qishenyiqi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode. Sci Rep 2015;5:11802.

    PubMed  PubMed Central  Google Scholar 

  6. Chen TG, Tan WL, Ma ZQ, et al. Effect of Qishenyiqi Dripping Pills on heart function and serum cytokines in the patients of chronic heart failure. Chin J Gerontol (Chin) 2011;31:742–744.

    CAS  Google Scholar 

  7. Fu JZ, Song SY, Jiang M, et al. Simultaneous determination of the contents of astragaloside W, danshensu, protocatechualdehyde, ginsenosides Rg 1 and Rb 1 in Qishenyiqi Dropping Pills by LC-MS. Chin Pharm J (Chin) 2012;47:61–64.

    CAS  Google Scholar 

  8. Liu LL, Wang GL. Effects of AstragaIus PoIysaccharides on the energy metabolism of cardiomyocytes in rats with chronic heart failure. Chin J Integr Med Cardio-/Cerebrovascul Dis (Chin) 2022;20:420–426.

    Google Scholar 

  9. Li ZH, Guan XS, Jiang LP. Astragaloside IV attenuates myocardial ischemia-reperfusion injury in mice through NRF2/HO-1 signaling pathway. Chin J Pathophysiol (Chin) 2021;37:2147–2153.

    Google Scholar 

  10. Feng KR, Li WX, Wang XY, et al. Chemical components and pharmacological action for Salviae Miltiorrhizae Radix et Rhizoma and predictive analysis on quality markers. Chin Tradit Herb Drugs (Chin) 2022;53:609–618.

    Google Scholar 

  11. Li J, Wang RF, Yang L, et al. Structure and biological action on cardiovascular systems of saponins from Panax notoginseng. China J Chin Mater Med (Chin) 2015;40:3480–3487.

    CAS  Google Scholar 

  12. Shou BY, Chen LY, Zhang N, et al. Different Dalbergia odorifera extracts inhibit acute myocardial ischemia injury in rats by regulation of energy metabolism. Chin Tradit Pat Med (Chin) 2021;43:374–380.

    Google Scholar 

  13. Lv XQ, Guo CC, Xu Y, et al. A proposed mechanism by which Qishen Yiqi Dropping Pill improves cardiac energy metabolism in rats with heart failure based on metabolomics and network pharmacology. Acta Pharm Sin (Chin) 2022;57:1387–1395.

    Google Scholar 

  14. Shao YP, Zhang W, Tong L, et al. Simultaneous determination of eight bioactive components of Qishen Yiqi Dripping Pills in rat plasma using UFLC-MS/MS and its application to a pharmacokinetic study. Biomed Chromatogr 2017;31:e3941.

    Google Scholar 

  15. Li M, Hou XF, Zhang J, et al. Applications of HPLC/MS in the analysis of traditional Chinese medicines. J Pharm Anal 2011;1:81–91.

    CAS  PubMed  Google Scholar 

  16. Yu J, Zhang W, Zhang Y, et al. A critical courier role of volatile oils from Dalbergia odorifera for cardiac protection in vivo by QiShenYiQi. Sci Rep 2017;7:7353.

    PubMed  PubMed Central  Google Scholar 

  17. Wu L, Zhang S, Zhou L, et al. Establishment and validation of the quantitative analysis of multi-components by single marker for the quality control of Qishen Yiqi Dropping Pills by high-performance liquid chromatography with charged aerosol detection. Phytochem Anal 2021;32:942–956.

    CAS  PubMed  Google Scholar 

  18. Li M, Li RM, Zhang YQ, et al. GC fingerprint of volatile components in Qishen Yiqi Dropping Pills. Chin Tradit Herb Drugs (Chin) 2016;47:1702–1708.

    CAS  Google Scholar 

  19. Chen JX, Xu X, Li ZF, et al. Qishen Yiqi Drop Pill improves cardiac function after myocardial ischemia. Sci Rep 2016;6:24383.

    CAS  Google Scholar 

  20. Han JY, Li Q, Pan CS, et al. Effects and mechanisms of QiShenYiQi Pills and major ingredients on myocardial microcirculatory disturbance, cardiac injury and fibrosis induced by ischemia-reperfusion. Pharmacol Res 2019;147:104386.

    CAS  PubMed  Google Scholar 

  21. Cui YC, Yan L, Pan CS, et al. The contribution of different components in QiShenYiQi Pills to its potential to modulate energy metabolism in protection of ischemic myocardial injury. Front Physiol 2018;9:389.

    PubMed  PubMed Central  Google Scholar 

  22. Zhang T, Zhang MX, Zhang YJ. Dynamic observation and mechanism of Qishen Yiqi Dropping Pills on myocardial ischemia in rats based on angiogenesis. Chin J Exp Tradit Med Form (Chin) 2017;23:134–139.

    Google Scholar 

  23. Pan CS, Yan L, Lin SQ, et al. QiShenYiQi Pills attenuates ischemia/reperfusion-induced cardiac microvascular hyperpermeability implicating Src/Caveolin-1 and RhoA/ROCK/MLC signaling. Front Physiol 2021;12:753761.

    PubMed  PubMed Central  Google Scholar 

  24. Chen J, Li L, Chen GH, et al. Protective effect of QishenYiqi Dripping Pills on rats with myocardial ischemia-reperfusion injury. Chin J Mod Med (Chin) 2017;27:30–34.

    Google Scholar 

  25. Zheng QN, Wei XH, Pan CS, et al. QiShenYiQi Pills® ameliorates ischemia/reperfusion-induced myocardial fibrosis involving RP S19-mediated TGFβ1/Smads signaling pathway. Pharmacol Res 2019;146:104272.

    PubMed  Google Scholar 

  26. Forood A, Malekpour-Afshar R, Sarnevesht J. Effect of opium addiction on aspirin resistance in stable angina pectoris. Addict Health 2014;6:7–13.

    PubMed  PubMed Central  Google Scholar 

  27. Cao H, Wang P, Li N, et al. Practice of comparative effectiveness research to identify treatment vharacteristics of similar Chinese patent medicine for angina pectoris. Evid-Based Complement Alternat Med 2017;2017:7062714.

    PubMed  PubMed Central  Google Scholar 

  28. Cao HB, Zhai JB, Li N, et al. CUPID: a protocol of a randomized controlled trial to identify characteristics of similar Chinese patent medicines. BMJ Open 2014;4:e006753.

    PubMed  PubMed Central  Google Scholar 

  29. Li X, Wu LH, Liu W, et al. A network pharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action. PLoS One 2014;9:e95004.

    PubMed  PubMed Central  Google Scholar 

  30. Yang Q, Cao Y. Study on mechanisms and myocardial protective effect of Qishen Yiqi Dropping Pills on rats with myocardial infarction. Chin Crit Care Med (Chin) 2017;29:501–505.

    Google Scholar 

  31. Wang Y, Lin WL, Li C, et al. Multipronged therapeutic effects of Chinese herbal medicine Qishenyiqi in the treatment of acute myocardial infarction. Front Pharmacol 2017;8:98.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Feng LM, Du WX, Zhu MD, et al. Experimental study on collagen repair of acute myocardial infarction with QiShen Yiqi Pills. Lishizhen Med Mater Med Res (Chin) 2010;21:3080–3082.

    Google Scholar 

  33. Shao ZB, Dai XH, Mao JY, et al. Effect of Qishen Yiqi Pills on heart function and hypersensitive C-reactive protein in patients with chronic heart failure. Chin J Exp Tradit Med Form (Chin) 2015;21:152–155.

    Google Scholar 

  34. Fu SF, Zhang JH, Gao XM, et al. Clinical practice of traditional Chinese medicines for chronic heart failure. Heart Asia 2010;2:24–27.

    PubMed  PubMed Central  Google Scholar 

  35. Lin S, Shi Q, Yang F, et al. Traditional Chinese medicine injections for heart failure: a protocol for systematic review and network meta-analysis of randomised controlled trials. BMJ Open 2020;10:e037331.

    PubMed  PubMed Central  Google Scholar 

  36. Hou YZ, Wang S, Zhao ZQ, et al. Clinical assessment of complementary treatment with Qishen Yiqi Dripping Pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF). Trials 2013;14:138.

    PubMed  PubMed Central  Google Scholar 

  37. Chen H, Li C, Shi TJ, et al. Influence of Qishen Yiqi Gutta Pills on RAAS in rats with heart failure. J Beijing Univ Tradit Chin Med (Chin) 2014;37:538–542.

    Google Scholar 

  38. Lv S, Wang Q, Wu M, et al. QiShenYiQi Pill improves myocardial hypertrophy caused by pressure overload in rats. Evid-Based Complement Alternat Med 2021;2021:5536723.

    PubMed  PubMed Central  Google Scholar 

  39. Lv SC, Wu MF, Li M, et al. Effect of QiShenYiQi Pill on myocardial collagen metabolism in rats with partial abdominal aortic coarctation. Evid-Based Complement Altern Med 2015;2015:415068.

    Google Scholar 

  40. Bracamonte-Baran W, iháková D. Cardiac autoimmunity: myocarditis. Adv Exp Med Biol 2017;1003:187–221.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Lv SC, Wu MF, Li M, et al. Effect and mechanism of QiShenYiQi Pill on experimental autoimmune myocarditis rats. Med Sci Monitor 2016;22:752–760.

    CAS  Google Scholar 

  42. Lv SC, Wu MF, Li M, et al. Effect of QiShenYiQi Pill on myocardial collagen metabolism in experimental autoimmune myocarditis rats. Biomed Pharmacother 2017;88:894–901.

    PubMed  Google Scholar 

  43. Adegbola P, Aderibigbe I, Hammed W, et al. Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review. Am J Cardiovasc Dis 2017;7:19–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Ananthan K, Lyon AR. The role of biomarkers in cardiooncology. J Cardiovasc Transl Res 2020;13:431–450.

    PubMed  PubMed Central  Google Scholar 

  45. Castro AR, Silva SO, Soares SC. The use of high sensitivity C-reactive protein in cardiovascular disease detection. J Pharm Pharm Sci 2018;21:496–503.

    PubMed  Google Scholar 

  46. Dai QQ, Shi ZF, Hu JY, et al. Meta-analysis of effect of Qishen Yiqi Dripping Pills combined with Western medicine on adverse cardiovascular events and quality of life after percutaneous coronary intervention. China J Chin Mater Med (Chin) 2021;46:1498–1510.

    Google Scholar 

  47. Guan XJ, Deng B, Zhou XJ, et al. Effects of Qishen Yiqi Pills on ventricular remodeling and inflammatory factors in patients with chronic heart failure. Lishizhen Med Mater Med Res (Chin) 2013;24:681–682.

    Google Scholar 

  48. Barhoumi T, Fraulob-Aquino JC, Mian MOR, et al. Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injury. Cardiovasc Res 2017;113:1753–1762.

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Li C, Wang Y, Qiu Q, et al. Qishenyiqi protects ligation-induced left ventricular remodeling by attenuating inflammation and fibrosis via STAT3 and NF-κB signaling pathway. PLoS One 2014;9:e104255.

    PubMed  PubMed Central  Google Scholar 

  50. Zhu MD, Du WX, Liu CY, et al. Dynamic observation of the effect of Qishen Yiqi Dropping Pills on the factors of myocarditis in AMI rats. Lishizhen Med Mater Med Res (Chin) 2013;24:22–25.

    Google Scholar 

  51. Horiuchi T, Mitoma H, Harashima S, et al. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 2010;49:1215–1228.

    CAS  PubMed  Google Scholar 

  52. Man SM, Kanneganti TD. Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat Rev Immunol 2016;16:7–21.

    CAS  PubMed  Google Scholar 

  53. Gao YF, Wang XJ, Yan WC, et al. Influence of Shenghuang Mixture on apoptosis related proteins Bax, Bcl-2 and Caspase-3 in myocardial ischemia-reperfusion rats. Chin J Exp Tradit Med Form (Chin) 2012;18:244–247.

    Google Scholar 

  54. Zhang S, Wang H, Li L, et al. Qishen Yiqi Drop Pill, a novel compound Chinese traditional medicine protects against high glucose-induced injury in cardiomyocytes. J Cell Mol Med 2019;23:6393–6402.

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Vaux DL, Weissman IL, Kim SK. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 1992;258:1955–1957.

    CAS  PubMed  Google Scholar 

  56. Lindsten T, Ross AJ, King A, et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 2000;6:1389–1399.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Montenont E, Echagarruga C, Allen N, et al. Platelet WDR1 suppresses platelet activity and is associated with cardiovascular disease. Blood 2016;128:2033–2042.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol 2019;16:166–179.

    CAS  PubMed  Google Scholar 

  59. Wang Y, Wang J, Guo L, et al. Antiplatelet effects of Qishen Yiqi Dropping Pill in platelets aggregation in hyperlipidemic rabbits. Evid-Based Complement Alternat Med 2012;2012:205451.

    PubMed  PubMed Central  Google Scholar 

  60. Li YX, Zhu J, Liu YL, et al. Glycogen synthase kinase 3β influences injury following cerebral ischemia/reperfusion in rats. Int J Biol Sci 2016;12:518–531.

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Jian J, Xuan FF, Qin FZ, et al. The antioxidant, antiinflammatory and anti-apoptotic activities of the bauhinia championii flavone are connected with protection against myocardial ischemia/reperfusion injury. Cell Physiol Biochem 2016;38:1365–1375.

    CAS  PubMed  Google Scholar 

  62. Hu R, Chen ZF, Yan J, et al. Endoplasmic reticulum stress of neutrophils is required for ischemia/reperfusion-induced acute lung injury. J Immunol 2015;195:4802–4809.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. Lin SQ, Wei XH, Huang P, et al. Qishenyiqi Pills prevent cardiac ischemia-reperfusion injury via energy modulation. Int J Cardiol 2013;168:967–974.

    PubMed  Google Scholar 

  64. Qiu Q, Wang W, Yang KX, et al. Effects of Qishen Yiqi Dropping Pills on apoptosis and related protein in ameroid narrow ring caused heart failure of miniature pigs. Chin Arch Tradit Chin Med (Chin) 2014;32:2082–2084.

    CAS  Google Scholar 

  65. Wu X, Reboll MR, Korf-Klingebiel M, et al. Angiogenesis after acute myocardial infarction. Cardiovasc Res 2021;117:1257–1273.

    CAS  PubMed  Google Scholar 

  66. Khan M, Meduru S, Pandian RP, et al. Effect of oxygenation on stem-cell therapy for myocardial infarction. Adv Exp Med Biol 2011;701:175–181.

    CAS  PubMed  Google Scholar 

  67. Hu JH, Chen SJ, Liu K, et al. Effect of Qishen Yiqi Pills on left ventricular diastolic function and plasma BNP in patients with diastolic heart failure. Chin Tradit Pat Med (Chin) 2015;37:959–961.

    Google Scholar 

  68. Wang K, Dai XH. Efficacy and safety of Qishen Yiqi Dripping Pill in improving left ventricular remodeling and cardiac function after acute myocardial infarction: a meta-analysis. Chin J Integr Med Cardio-/Cerebrovascular Dis (Chin) 2019;17:653–658.

    Google Scholar 

  69. Lu Y, Wang D, Yuan X, et al. Protective effect of Qishen Yiqi Dropping Pills on the myocardium of rats with chronic heart failure. Exp Ther Med 2019;17:378–382.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China

    Chun-miao Lu & Ya-ping Zhu

  2. Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China

    Yu-song Yang

  3. Institute of Acute Abdominal Diseases, Nankai Hospital, Tianjin, 300100, China

    Yan-min Lu

  4. Epidemiology, College of Global Public Health, New York University, New York, 10003, USA

    Ao Zhang

  5. Department of Geriatric Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China

    Shi-chao Lyu & Jun-ping Zhang

Authors
  1. Chun-miao Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu-song Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yan-min Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ya-ping Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shi-chao Lyu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jun-ping Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Lu CM and Lyu SC collected literature and wrote the article; Yang YS and Zhang A gathered the material, Lu YM made forms, Zhu YP reconsidered the research plan and Zhang JP made suggestions for the framework of the article.

Corresponding author

Correspondence to Shi-chao Lyu.

Ethics declarations

The authors declare no conflicts of interest.

Additional information

Supported by National Natural Science Foundation of China (No. 81603559)

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lu, Cm., Yang, Ys., Lu, Ym. et al. Qishen Yiqi Dripping Pills for Cardiovascular Diseases: Effects and Mechanisms. Chin. J. Integr. Med. 29, 857–864 (2023). https://doi.org/10.1007/s11655-022-3288-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-022-3288-2

Keywords

Search

Navigation